Literature DB >> 3767464

Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.

R A Asherson, A G Benbow, C J Speirs, N Jackson, G R Hughes.   

Abstract

A patient who developed pulmonary hypertension and systemic lupus erythematosus as a complication of hydralazine therapy is reported. She was a slow acetylator and in addition was found to have a null allele at the C4A locus.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3767464      PMCID： PMC1001985          DOI： 10.1136/ard.45.9.771

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  27 in total

1.  Pulmonary hypertension in rheumatoid arthritis: report of a case with intimal sclerosis of the pulmonary and digital arteries.

Authors:  D L GARDNER; J J DUTHIE; J MACLEOD; W S ALLAN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

Review 2.  Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Authors:  H M Perry
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

3.  Pulmonary hypertension in systemic sclerosis.

Authors:  E Trell; C Lindström
Journal:  Ann Rheum Dis       Date:  1971-07       Impact factor: 19.103

4.  Pulmonary hypertension and systemic lupus erythematosus.

Authors:  R A Asherson; C M Oakley
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

5.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson; C G Mackworth-Young; M L Boey; R G Hull; A Saunders; A E Gharavi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

6.  Hydralazine induced lupus syndrome with eye disease.

Authors:  M Doherty; P J Maddison; R H Grey
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

Review 7.  Drug-induced lupus: clinical and serological studies.

Authors:  C E Harmon; J P Portanova
Journal:  Clin Rheum Dis       Date:  1982-04

8.  Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  F P Quismorio; O Sharma; M Koss; T Boylen; A W Edmiston; P J Thornton; D Tatter
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

9.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).

Authors:  R Salerni; G P Rodnan; D F Leon; J A Shaver
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

10.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  D D Gladman; L Sternberg
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666
View more
  1 in total

1.  Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.

Authors:  R A Asherson; J Zulman; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.